Patient-Specific Treatment Sandboxes

Projection: multimodal models will first become valuable as treatment sandboxes, not autonomous prescribers. They can integrate records, imaging, wearables, and genomics to compare plausible pathways, surface evidence conflicts, and identify what new measurement would change the decision, leaving final judgment with qualified clinicians.